Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts

Am J Hematol. 2015 Jul;90(7):E139-41. doi: 10.1002/ajh.24036. Epub 2015 May 28.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Age Factors
  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Decitabine
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / pathology
  • Male
  • Middle Aged
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Decitabine
  • Azacitidine